Zhongnan Medical Journal Press

Home Results

A total of 32 result was found. Results that relate to Health technology assessment

HLA-B*5801 gene polymorphisms detection in prediction of severe drug eruption associated allopurinol: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(9):1044-1053.
14769 times 2375 times

CAO Jinjin LING Ya ZHANG Jie ZHANG Jingjing ZHU Jianguo CAO Xiufang

Allopurinol HLA-B*5801 gene testing Severe drug eruption Rapid health technology assessment
Details
Edaravone in the treatment of acute ischemic stroke: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1147-1155.
13510 times 2451 times

YU Fang ZENG Lu WEI Anhua GONG Xuepeng WANG Lu

Edaravone Acute ischemic stroke Efficacy Safety Economy Rapid health technology assessment
Details
Efgartigimod alfa in the treatment of generalized myasthenia gravis: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1156-1163.
12226 times 2425 times

HUANG Gerile LI Yujie ZHANG Wenjing GUO Hao

Efgartigimod alfa Myasthenia gravis Rapid health technology assessment Efficaey Safety Economy
Details
Tofacitinib for the treatment of ulcerative colitis: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(12):1414-1424.
18430 times 2225 times

LI Huiling DUAN Yinyin LI Qianqian WU Xiaoli

Tofacitinib Ulcerative colitis Rapid health technology assessment
Details
Vonoprazan for ulcers associated with endoscopic submucosal dissection: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(3):306-313.
11686 times 2055 times

WANG Wei KE Yijun CHENG Chang FANG Chongwen PAN Lisheng JIN Yong ZHANG Yanping

Vonoprazan Endoscopic submucosal dissection Ulcer Rapid health technology assessment
Details
Venetoclax in the treatment of non-M3 acute myeloid leukemia: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(3):314-323.
12768 times 1967 times

ZHANG Yazhuo LI Huiling Duan Yinyin SHI Yuye

Venetoclax Non-M3 acute myeloid leukemia Rapid health technology assessment
Details
Dorzagliatin in the treatment of type 2 diabetes：a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(4):448-455.
19372 times 3611 times

LI Yujie ZHANG Wenjing YANG Hongxin GUO Hao

Dorzagliatin Type 2 diabetes mellitus Rapid health technology assessment Efficacy Safety Economy
Details
Sugemalimab as first-line treatment for non-small cell lung cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):806-814.
11294 times 1835 times

HOU Yibing KANG Shuo GONG Yuan WANG Xiaohui NIE Ying LIU Huanlong

Sugemalimab Non-small cell lung cancer Effectiveness Safety Economics Rapid health technology assessment
Details
Tirzepatide in the treatment of type 2 diabetes mellitus: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(9):1057-1065.
16424 times 2249 times

ZHANG Yunxuan ZHOU Haifeng GAO Ningzhou WU Jianbo QIAN Cheng ZHANG Min GUO Han SONG Zhongjuan LIU Xiaoyan

Tirzepatide Type 2 diabetes mellitus Rapid health technology assessment Efficacy Safety Cost-effectiveness
Details
Inclisiran in the treatment of dyslipidemia: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(10):1198-1205.
8542 times 1659 times

CHEN Lingbin PAN Weiping CHEN Zhou XU Wentan

Inclisiran Dyslipidemia Efficacy Safety Cost-effectiveness Rapid health technology assessment
Details
Rapid health technology assessment of linezolid for the treatment of complicated lower respiratory tract infections

Published on Frontiers in Pharmaceutical Sciences 2025,29(10):1731-1737.
6580 times 1159 times

LANG Yan PAN Jiahui WANG Ling

Linezolid Lower respiratory tract infection Rapid health technology assessment
Details
Toripalimab for the treatment of advanced esophageal cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1302-1310.
6460 times 1278 times

YANG Shou NIE Ying GONG Yuan KANG Shuo HOU Yibing WANG Xiaohui PAN Zhenhua

Toripalimab Advanced esophageal cancer Rapid health technology assessment Effectiveness Safety Economy
Details
Rapid health technology assessment of avatrombopag for the treatment of primary immune thrombocytopenia in adults

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1311-1319.
8075 times 1318 times

LI Zhou LING Ya ZHANG Jie ZHU Ling

Avatrombopag Primary immune thrombocytopenia Efficacy Safety Economy Rapid health technology assessment
Details
Rapid health technology assessment of crisaborole in the treatment of mild-to-moderate atopic dermatitis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(12):1423-1433.
6397 times 1104 times

ZHANG Jinfen TONG Ruofei YANG Lin SUN Yanyan

Crisaborole Atopic dermatitis Rapid health technology assessment Efficacy Safety Economy
Details
Oliceridine injection for postoperative analgesia: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(12):1434-1440.
4671 times 1024 times

ZHOU Jing LUO Hao ZHENG Xiaoke CAI Jingyue XIE Caipeng TAN Qiuhua

Oliceridine Postoperative analgesia Efficacy Safety Economy Rapid health technology assessment
Details